Characterization of prolactin receptor in human brain and choroid plexus.
We have studied the binding of 125I-labeled human prolactin (PRL) to membranes from various regions of the human brain (hypothalamus, cerebral cortex, cerebellum and choroid plexus) derived from autopsy specimens. Among the various regions studied, the choroid plexus of both male and female subjects showed the highest specific binding and a clearly detectable specific binding was also observed in the hypothalamus of both sexes, whereas it was very low in other brain regions. No significant sex differences in PRL binding to various brain regions were observed except for the hypothalamus where a higher binding was seen in female subjects. The binding did not vary with the age of the subjects. Moreover, the cause of death and the time elapsed from death to autopsy in this study did not affect the binding significantly. The binding of 125I-labeled human PRL to hypothalamus and choroid plexus membranes from female specimens was inhibited in a dose-dependent manner by both unlabeled human and ovine PRL and by human growth hormone (GH), but not by other polypeptide hormones. Scatchard analysis of the binding revealed the presence of saturable binding sites with low capacity and high affinity for human PRL ligand. These results provide strong preliminary evidence for the presence of PRL binding sites in the human brain.
Di Carlo
R
R
Department of Experimental Pharmacology, University of Naples Federico II, Italy.
Muccioli
G
G
Papotti
M
M
Bussolati
G
G
D000818:Animals; D001923:Brain Chemistry / Q000502:physiology*; D002831:Choroid Plexus / Q000737:chemistry*; D005260:Female; D006801:Humans; D008297:Male; D051381:Rats; D011981:Receptors, Prolactin / Q000032:analysis*
D011981:Receptors, Prolactin